A message sent from the brain may help calm an inflamed liver, according to new research from McMaster University.
The surprising discovery began with GDF15, a natural hormone usually discussed because of its ability to reduce hunger.
Scientists now report that GDF15 can protect the liver even when it does not cause weight loss. That distinction is important because it suggests the hormone has a second job that researchers had not fully understood.
The finding could be especially relevant to MASH, a severe form of fatty liver disease. MASH develops when fat builds up in the liver and is accompanied by ongoing inflammation and injury to liver cells.
The liver normally performs hundreds of essential jobs, including processing nutrients, removing harmful substances and producing proteins needed throughout the body. It can also repair itself remarkably well, but years of repeated injury can overwhelm that ability.
When liver inflammation continues, the body tries to repair the damage by producing scar tissue. Small amounts of scarring may be manageable, but increasing fibrosis can eventually change the structure of the liver and lead to cirrhosis.
At that point, the risk of liver failure and liver cancer rises. Because MASH is often associated with obesity and type 2 diabetes, its growing prevalence has become a major health concern as metabolic disease becomes more common worldwide.
One of the most effective ways to improve fatty liver disease is to lose weight. Losing enough weight can reduce liver fat and may improve inflammation, which is why newer obesity medicines have attracted attention as possible tools against liver disease.
But weight loss does not solve every part of the problem. Some patients can continue to have harmful liver inflammation, creating a need for treatments that address the immune and scarring processes more directly.
The McMaster researchers investigated whether GDF15 could provide such a clue. They used mice with disease features similar to human MASH and combined genetic studies, medicines and detailed analysis of activity in different parts of the liver.
What they uncovered was an unexpected communication route. GDF15 first acted through the brain, which then sent signals through the nervous system that led the body to release glucocorticoids.
These naturally occurring steroid hormones influence many processes, including stress responses and immune activity. The researchers found that this hormonal signal reduced inflammatory activity inside the liver.
Closer examination showed that GDF15 changed the behavior of immune cells in the liver. Instead of remaining in a highly active state that can contribute to tissue injury, some cells shifted toward a calmer and more protective pattern.
The effect also appeared to reduce fibrosis, the dangerous buildup of scar tissue. Crucially, these improvements were seen separately from changes in how much the animals ate, how much they weighed or how much fat was stored in their livers.
That result changes the way GDF15 can be viewed. If the liver improvements had occurred only after weight loss, scientists could reasonably assume they were simply a result of reduced body fat and better metabolism.
Instead, the study points to a separate biological pathway linking the brain, nervous system, hormones and liver immune response. It suggests that the body may have a built-in system for limiting liver damage during periods of chronic stress.
The same McMaster researchers previously reported another unexpected function for GDF15. Their 2023 work showed that the hormone helps preserve calorie burning during weight loss, indicating that GDF15 may coordinate several responses when the body is under metabolic stress.
The new discovery could influence future drug development. Rather than relying only on therapies that help patients lose weight or remove fat from the liver, researchers may be able to design treatments that also quiet harmful inflammation and slow scarring.
There are important limits to the findings, however. The experiments largely involved animal models, so researchers cannot yet assume that stimulating this pathway will safely prevent MASH from progressing in people.
The pathway also involves glucocorticoids, hormones with powerful effects throughout the body. Long-term exposure to high levels of these hormones can have harmful consequences, which means any future therapy would need to reproduce the liver-protective effect without creating new problems elsewhere.
Even with those cautions, the study provides a useful new direction because it explains a biological mechanism rather than simply showing an association. The strongest part of the work is the evidence that liver protection can occur without weight loss, while the biggest unanswered question is whether the same pathway can be safely used in human patients.
The research was published in Cell Metabolism on August 10, 2026. Further human research will be needed, but the findings suggest that treating advanced fatty liver disease may eventually require two goals at once: improving metabolism and directly controlling the inflammation that damages the liver.
If you care about liver health, please read studies that refined fiber is link to liver cancer, and the best and worst foods for liver health.
For more health information, please see recent studies about how to boost your liver naturally, and simple ways to detox your liver.
Source: McMaster University.
